Filing Details
- Accession Number:
- 0001179110-17-006992
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-10 17:03:09
- Reporting Period:
- 2017-05-08
- Filing Date:
- 2017-05-10
- Accepted Time:
- 2017-05-10 17:03:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200493 | E Dorothy Puhy | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2017-05-08 | 13,500 | $18.63 | 38,249 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-05-08 | 6,631 | $130.63 | 31,618 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-05-08 | 5,758 | $131.42 | 25,860 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2017-05-08 | 1,111 | $132.50 | 24,749 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-05-08 | 13,500 | $0.00 | 13,500 | $18.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-08-12 | 2018-08-13 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $7.67 | 2010-08-11 | 2019-08-12 | 0 | 13,500 | Direct |
| Common Stock | Stock Option (right to buy) | $9.99 | 2011-08-10 | 2020-08-11 | 0 | 13,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-08-12 | 0 | 13,500 | Direct |
| 2020-08-11 | 0 | 13,500 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This option becomes exerciseable in full on the date set forth in Table II, Column 6.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $130.0200 and $131.0100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $131.0500 and $132.0350. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $132.0500 and $133.4175. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer
Billionaire Hedge Funds
